Sarepta, Aldevron Partnering to Develop Gene Therapies for CMT, Other Rare Diseases
Aldevron signed a long-term agreement with Sarepta Therapeutics to provide the gene-transfer vehicles for Sarepta’s gene therapies.
1 Comment
Sarepta, Aldevron Partnering to Develop Gene Therapies for CMT, Other Rare Diseases
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed